Your browser doesn't support javascript.
loading
Analysis of SARS-CoV-2 reverse transcription-quantitative polymerase chain reaction cycle threshold values vis-à-vis anti-SARS-CoV-2 antibodies from a high incidence region.
Markewitz, Robert; Torge, Antje; Wandinger, Klaus-Peter; Pauli, Daniela; Dargvainiene, Justina; Franke, Andre; Bujanda, Luis; Marimón, José Maria; Banales, Jesus M; Gutierrez-Stampa, María A; Nafría, Beatriz; Junker, Ralf.
Afiliação
  • Markewitz R; Institute of Clinical Chemistry, University Hospital Schleswig-Holstein, Kiel, Lübeck, Germany. Electronic address: robert.markewitz@uksh.de.
  • Torge A; Institute of Clinical Chemistry, University Hospital Schleswig-Holstein, Kiel, Lübeck, Germany.
  • Wandinger KP; Institute of Clinical Chemistry, University Hospital Schleswig-Holstein, Kiel, Lübeck, Germany.
  • Pauli D; Institute of Clinical Chemistry, University Hospital Schleswig-Holstein, Kiel, Lübeck, Germany.
  • Dargvainiene J; Institute of Clinical Chemistry, University Hospital Schleswig-Holstein, Kiel, Lübeck, Germany.
  • Franke A; Institute of Clinical Molecular Biology, Christian-Albrechts-University of Kiel & University Hospital Schleswig-Holstein, Kiel, Germany.
  • Bujanda L; Department of Liver and Gastrointestinal Diseases, Biodonostia Health Research Institute - Donostia University Hospital, San Sebastián, Spain; National Institute for the Study of Liver and Gastrointestinal Diseases (CIBERehd, "Instituto de Salud Carlos III"), University of the Basque Country (UPV/EH
  • Marimón JM; Biodonostia Health Research Institute, Infectious Diseases Area, Respiratory Infection and Antimicrobial Resistance Group, Osakidetza Basque Health Service, Donostialdea Integrated Health Organisation, Microbiology Department, San Sebastián, Spain.
  • Banales JM; Department of Liver and Gastrointestinal Diseases, Biodonostia Health Research Institute - Donostia University Hospital, San Sebastián, Spain; National Institute for the Study of Liver and Gastrointestinal Diseases (CIBERehd, "Instituto de Salud Carlos III"), University of the Basque Country (UPV/EH
  • Gutierrez-Stampa MA; Osakidetza, OSI Donostialdea, Altza Primary Care; Biodonostia Health Research Institute, San Sebastián, Spain.
  • Nafría B; Clinical Biochemistry Department, Biodonostia Health Research Institute Osakidetza Basque Health Service, Donostialdea Integrated Health Organisation. San Sebastián, Spain.
  • Junker R; Institute of Clinical Chemistry, University Hospital Schleswig-Holstein, Kiel, Lübeck, Germany.
Int J Infect Dis ; 110: 114-122, 2021 Sep.
Article em En | MEDLINE | ID: mdl-34273511
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Tipo de estudo: Incidence_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Int J Infect Dis Assunto da revista: DOENCAS TRANSMISSIVEIS Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Tipo de estudo: Incidence_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Int J Infect Dis Assunto da revista: DOENCAS TRANSMISSIVEIS Ano de publicação: 2021 Tipo de documento: Article